MedPath

Ayurvedic treatment of Kashtartava(Primary Dysmenorrhoea)

Completed
Conditions
Primary dysmenorrhea,
Registration Number
CTRI/2020/07/026892
Lead Sponsor
ICMR
Brief Summary

Research project - Clinical Evaluation of the efficacy of Ayurvedic treatment regimen in the management of Kashtartava (Primary Dysmenorrhoea ) is approved and DSMB has  already given clearance. In the view of pendamic going on, study may take sometime to start as local therapy is to be done in the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
180
Inclusion Criteria

Females of age group of 15 to 24 years At least 3 painful cycle (21-35 days’ cycle) in last 6 cycles and intensity of pain during menstruation ≥ 40 mm (as per VAS) Duration of menstrual pain ≥ 1 day Able and willing to participate and provide signed informed consent.

Exclusion Criteria

Patients having Secondary Dysmenorrhoea Patients on prolonged (>2weeks) medication with corticosteroids, anti depressants anticholinergic or any systemic/chronic illness which may have effect on menstrual cycle Planning for Pregnancy during the treatment period and lactation Patients having any mental / psychiatric illness will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the intensity of menstrual pain by using VAS scaleAt base line, at the | end of 1st, 2nd, 3 rd, 4 th, 5th, and 6th menstrual cycle
Secondary Outcome Measures
NameTimeMethod
Changes in other signs and symptoms by using Verbal Multi-dimensional scoring system and Menstrual Distress questionnaireChanges in the quality of life of the study participants by using Health Survey – SF – 36 Questionnaire (RAND)

Trial Locations

Locations (1)

All India Institute of Ayurveda

🇮🇳

South, DELHI, India

All India Institute of Ayurveda
🇮🇳South, DELHI, India
Dr Kamini Dhiman
Principal investigator
8512813414
kd44ayu@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.